Platelet-Rich Plasma and BMCC (Bone Marrow Cell Concentrate) Explained:
What is Platelet-Rich Plasma (PRP)?
Platelet-rich plasma or PRP is an "autologous blood therapy" that uses a patient's own blood components to stimulate a healing response in damaged
tissues. In response to an injury or tissue damage, your body naturally recruits platelets and white blood cells from the blood to initiate a
healing response. Under normal conditions, platelets store numerous growth factors which are released in response to signals from the injured
tissue. Modern technology allows us to concentrate platelets and white blood cells from your blood, and induce this growth factor release as
we inject the solution directly into injured tissue, simulating this same healing response in a more powerful form. By enhancing the body's
natural healing capacity, the treatment may lead to a more rapid, more efficient, and more thorough restoration of the tissue to a healthy state.
What is Bone Marrow Cell Concentrate (BMCC)?
It is well established that a significant population of our bodies' stem cells are contained within our bone marrow. By harvesting blood and
tissue from the bone marrow space of the hip, an injectable product can be produced by concentrating platelets and cells withdrawn through a
simple outpatient needle aspiration procedure, done with local anesthetic and light sedation. BMCC contains all of the growth and healing
factors in PRP, along with concentrated "pluripotent" or stem-like cells which further contribute to the regenerative process.
What conditions can be treated with PRP and BMCC?
- Tendon Injuries (Patellar Tendonitis, Quad Tendon)
- Muscle injuries
- Ligament sprains or tears (MCL, LCL)
Shoulder and Arm Pain
- Muscle pain or injury
- Pyriformis syndrome
- Greater Trochanteric Bursitis
- Tendon Injuries
- Sacroiliac joint pain
- Hamstring tendonitis or tears
Lower Leg and Foot Pain
- Rotator Cuff tendonitis, tendonopathy or partial tears
- Bicipital tendonitis
- Medial and Lateral epicondylitis (golfers & tennis elbow)
- Ulnar Collateral Ligament sprain or tear
- Plantar Fasciitis
- Shin Splints
- Peroneal tendonitis
- Ankle sprains/ligament injury
- Achilles tendonitis or partial tears
Following a formal evaluation and diagnostic workup, an individualized treatment plan will be discussed with you. A full explanation of the procedure including risks and benefits will be reviewed. Once written consent is obtained, blood is drawn from your arm or from a bone marrow aspiration in the back of your hip region, and placed in a special processing unit, which separates platelets, white blood cells and serum from red blood cells. The platelets and white blood cells (including stem cells) are then concentrated and collected into a sterile syringe. Some of the blood is used to create an "activator" of the PRP/BMCC. The skin and soft tissue is anesthetized with local anesthetic, followed by injection of both the PRP/BMCC and activator into the tissue targeted for treatment. Depending on the size of the injured tissue, one or several needles are inserted to optimize placement of the product.
Depending on the severity and duration of your injury, one to three injections are suggested. Following the initial treatment with PRP or BMCC, a follow up visit occurs 3-4 weeks later. At this visit an evaluation of your response to the initial therapy is performed and a decision is made regarding the need for additional PRP treatments. In general, chronic injuries often require more than one injection. In both acute and chronic injuries, injections may be combined with an exercise or physical therapy program to enhance the success of the treatment.
Are PRP and BMCC injections safe?
Research and clinical data show that PRP and BMCC injections are extremely safe, with minimal risk for any adverse reaction or complication. Because the injectable products are produced from your own blood, there is no concern for rejection or disease transmission. There is a small risk of infection from any injection into the body, but this is rare. Of note, recent research suggests that PRP may have an anti-bacterial property which protects against possible infection (4).
What to expect after your treatment:
Often, following the initial injection, an "achy" soreness is felt at the site of injury. This "soreness" is a positive sign that a healing response has been set in motion. This effect can last for several days and gradually decreases as healing and tissue repair occurs. It is important that anti-inflammatory medications such as Ibuprofen, Naproxen and Aspirin be avoided following PRP treatments. These medicines may block the effects of the intended healing response facilitated by the injection itself. It is acceptable to use over the counter pain medication, such as Tylenol and in some cases a prescribed analgesic, which does not have anti-inflammatory properties, to control discomfort as needed. Pain management options will be discussed with you by the physician managing your treatment plan. You will be permitted to resume normal day to day activities and light exercise following injection. We suggest that you avoid strenuous lifting or high level exercise for at least several days after injection.
How do I find out if PRP or BMCC is right for me?
Questions regarding PRP or your candidacy for the treatments can be addressed to Dr. Karli at the Steadman Clinic in Vail, Colorado. Contact person for the PRP treatment program is
Benjamin Dale (970) 479-2701 firstname.lastname@example.org
. We would be happy to review a brief history of your problem via telephone in order to determine if a formal evaluation is warranted.
1. Anitua E, S. M., Nurden A, Nurden P, Orive G, Andia I. (2006). "New insights into and novel applications for platelet-rich fibrin therapies." Trends in Biotechnology 24(5): 227-234.
2. Mishra A, A. J., Anitua E, Andia I, Padilla S, Mujika I. (2007). "Treatment of chronic elbow tendinosis with buffered platelet-rich plasma." Am J of Sports Med 34(11): 1774-1778.
3. Moojen D, E. P., Schure R, et al. (2007). "Antimicrobial activity of platelet-leukocyte gel against Staphylococcus anreus." Journal of Orthopaedic Research DOI: 10.1002/jor.20519.
4. Sanchez M, A. E., Azofra J, Andia I, Padilla S, Mujika I. (2007). "Comparison of Surgically Repaired Achilles Tendon Tears Using Platelet-Rich Fibrin Matrices." Am J of Sports Med 10(10): 1-7.
5. Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2009). Platelet-rich plasma: From basic science to clinical applications. The American Journal of Sports Medicine, 2259-2272.
6. Fortier, L. A., Potter, H. G., Rickey, E. J., Schnabel, L. V., Foo, L. F., Chong, L. R., Stokol, T., & Cheetham, J. (2010). Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. The Journal of Bone and Joint Surgery, 92(10), 1927-1937.
7. Fortier, L. A., Barker, J. U., Strauss, E. J., McCarrel, T. M., & Cole, B. J. (2011). The role of growth factors in cartilage repair. Clinical Orthopaedics and Related Research, 469(10), 2706-2715.